Fate Therapeutics Correlations

FATE Stock

USD 1.12 0.03 2.75%

The current 90-days correlation between Fate Therapeutics and Caribou Biosciences is 0.15 (i.e., Average diversification). The correlation of Fate Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Fate Therapeutics Correlation With Market

Modest diversification

The correlation between Fate Therapeutics and DJI is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fate Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade Fate Stock refer to our How to Trade Fate Stock guide.

Moving together with Fate Stock

0.69	INZY	Inozyme Pharma	Pair Corr
0.91	KURA	Kura Oncology	Pair Corr
0.89	ABOS	Acumen Pharmaceuticals	Pair Corr
0.91	ADTX	Aditxt Inc	Pair Corr
0.73	ANAB	AnaptysBio	Pair Corr
0.9	STRO	Sutro Biopharma	Pair Corr
0.94	TCRX	Tscan Therapeutics	Pair Corr
0.79	TERN	Terns Pharmaceuticals	Pair Corr
0.82	CRNX	Crinetics Pharmaceuticals Buyout Trend	Pair Corr
0.7	CRSP	Crispr Therapeutics	Pair Corr
0.71	CTMX	CytomX Therapeutics	Pair Corr
0.72	DAWN	Day One Biopharmaceu	Pair Corr
0.64	TLKMF	Telkom Indonesia Tbk	Pair Corr

Moving against Fate Stock

0.6	OPT	Opthea	Pair Corr
0.58	PFE	Pfizer Inc	Pair Corr
0.54	GANX	Gain Therapeutics	Pair Corr
0.54	LTRN	Lantern Pharma	Pair Corr
0.52	PHGE	Biomx Inc	Pair Corr
0.43	CUE	Cue Biopharma	Pair Corr
0.37	FENC	Fennec Pharmaceuticals	Pair Corr
0.63	CGTX	Cognition Therapeutics	Pair Corr
0.53	DBVT	DBV Technologies Earnings Call This Week	Pair Corr
0.8	OBI	Ondine Biomedical	Pair Corr
0.8	SSNLF	Samsung Electronics	Pair Corr
0.54	GPI	Group 1 Automotive	Pair Corr
0.51	EC	Ecopetrol SA ADR Sell-off Trend	Pair Corr

Related Correlations Analysis

	ATRA	SANA	CRBU	RCUS	NTLA	EDIT	CRSP	VERV	THRX	LIFE
ATRA		-0.34	0.6	0.62	0.44	-0.03	-0.05	-0.48	0.0	0.0	ATRA
SANA	-0.34		-0.38	-0.44	-0.43	-0.04	0.0	0.47	0.0	0.0	SANA
CRBU	0.6	-0.38		0.85	0.86	0.39	0.43	-0.54	0.0	0.0	CRBU
RCUS	0.62	-0.44	0.85		0.61	0.01	0.12	-0.45	0.0	0.0	RCUS
NTLA	0.44	-0.43	0.86	0.61		0.7	0.73	-0.4	0.0	0.0	NTLA
EDIT	-0.03	-0.04	0.39	0.01	0.7		0.85	-0.11	0.0	0.0	EDIT
CRSP	-0.05	0.0	0.43	0.12	0.73	0.85		0.11	0.0	0.0	CRSP
VERV	-0.48	0.47	-0.54	-0.45	-0.4	-0.11	0.11		0.0	0.0	VERV
THRX	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	THRX
LIFE	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		LIFE
	ATRA	SANA	CRBU	RCUS	NTLA	EDIT	CRSP	VERV	THRX	LIFE

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

NTLA	+ 0.86	CRBU
RCUS	+ 0.85	CRBU
CRSP	+ 0.85	EDIT
CRSP	+ 0.73	NTLA
EDIT	+ 0.7	NTLA
RCUS	+ 0.62	ATRA

High negative correlations

VERV	- 0.54	CRBU
VERV	- 0.48	ATRA
VERV	- 0.45	RCUS
RCUS	- 0.44	SANA
NTLA	- 0.43	SANA
VERV	- 0.4	NTLA

Risk-Adjusted Indicators

There is a big difference between Fate Stock performing well and Fate Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fate Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ATRA	6.28	(0.18)	0.00	(0.19)	0.00	0.00	13.88	(10.34)	55.97
SANA	7.87	1.43	0.20	0.48	6.23	(10.91)	12.46	(11.88)	176.41
CRBU	3.05	(0.71)	0.00	(2.23)	0.00	0.00	8.22	(7.09)	17.35
RCUS	2.56	(0.54)	0.00	1.61	0.00	0.00	3.24	(5.66)	24.78
NTLA	3.53	(0.35)	0.00	(0.36)	0.00	0.00	7.84	(7.09)	22.98
EDIT	6.39	0.42	0.04	0.14	8.56	(7.64)	12.04	(9.59)	119.53
CRSP	2.87	0.00	0.00	(0.03)	0.00	0.00	6.48	(4.98)	19.32
VERV	5.32	0.74	0.14	0.39	4.68	(6.52)	11.24	(7.99)	36.90
THRX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
LIFE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Fate Therapeutics Corporate Management

Barbara Hickingbottom	Senior Development	Profile
Andrew Henry	Senior Operations	Profile
YuWaye MD	Chief Officer	Profile
Cindy Tahl	General Secretary	Profile
Edward III	Chief Officer	Profile
Bahram Valamehr	Chief Development Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC